Baas@Work Competitors

Alert Logic, a LevelBlue company, helps organizations detect threats earlier, respond faster, and reduce cyber risk across modern IT environments. Achieve comprehensive security coverage with extended detection and response (XDR), managed detection and response (MDR), and managed web application firewall (WAF) solutions for public cloud, hybrid, and on-premises environments.

CloudX drives significant growth and transformation for the world's most demanding organizations using AI and cutting-edge technologies. Our combination of Fast Impact Teams, technical expertise, and client-focused approach distinguishes us in a competitive market. We specialize in driving Cognitive Transformation by crafting Enterprise AI Agents that deliver measurable results. We go beyond basic AI implementations, automating complex workflows to significantly reduce operational costs and empower your teams to focus on strategic objectives. Our proven expertise in building diverse software solutions enables us to confidently tackle any technology challenge. We deliver scalable, production-ready AI solutions that yield tangible results, earning the trust of the most demanding organizations. Our 100% AI-certified team strategically leverages AI's strengths, ensuring optimal performance and measurable business value. In August 2026, CloudX was acquired by Bridgenext, a global digital consultancy with a strong engineering culture. This strategic decision helped expand Bridgenext’s engineering depth and near-shore delivery model. Together, we are better positioned to help clients turn AI ambition into scalable, practical solutions that deliver meaningful returns.

In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group. About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.